Reply: Fixed 3.7-GBq ¹³¹I Activity for Metastatic Thyroid Cancer Therapy Ignores Science and History

Affiliations

Free article

Comment

Desiree Deandreis. J Nucl Med. 2017 Sep.

Free article

. 2017 Sep;58(9):1531.

doi: 10.2967/jnumed.117.193185. Epub 2017 Apr 27.

¹ Gustave Roussy 114 Rue Edouard Vaillant Villejuif, France 94805 E-mail: desiree.deandreis@unito.it.

No abstract available

Comment on

Comparison of Empiric Versus Whole-Body/-Blood Clearance Dosimetry-Based Approach to Radioactive Iodine Treatment in Patients with Metastases from Differentiated Thyroid Cancer.
Deandreis D, Rubino C, Tala H, Leboulleux S, Terroir M, Baudin E, Larson S, Fagin JA, Schlumberger M, Tuttle RM. Deandreis D, et al. J Nucl Med. 2017 May;58(5):717-722. doi: 10.2967/jnumed.116.179606. Epub 2016 Oct 13. J Nucl Med. 2017. PMID: 27738010
Fixed 3.7-GBq ¹³¹I Activity for Metastatic Thyroid Cancer Therapy Ignores Science and History.
Jentzen W, Nahum AE, Bockisch A, Binse I, Tulchinsky M. Jentzen W, et al. J Nucl Med. 2017 Sep;58(9):1530. doi: 10.2967/jnumed.117.192872. Epub 2017 Apr 6. J Nucl Med. 2017. PMID: 28385792 No abstract available.